Showing results (921-930 of 1,008) with videos related to

Sort By:
Pageof 101
International Journal of Radiation Oncology, Biology, Physics|March 17, 2023
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim AnalysisSteven G Allen, Benjamin S Rosen, Madhava Aryal, et al.
Science Advances|July 23, 2025
Observations of a splitting ocean cyclone resulting in subduction of surface watersLeo Middleton, Weiguang Wu, T M Shaun Johnston, et al.
Nature Communications|December 11, 2021
Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patientsMichael Maschan, Paolo F Caimi, Jane Reese-Koc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck CancerMichelle L Mierzwa, Madhava Aryal, Choonik Lee, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 25, 2021
Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing BioselectionMolly E Heft Neal, Joshua D Smith, Andrew C Birkeland, et al.
Journal of the American Veterinary Medical Association|March 25, 2026
SARS-CoV-2 infections among animals in US zoological institutions resulted primarily from human-to-animal transmission without evidence of sustained evolution in animals (2020-2023)Dominic J Cristiano, Kate E Varela, Chelsea E Anderson, et al.
Advances in Radiation Oncology|August 21, 2025
Prospective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx CancerSamuel Nicholas Regan, Jennifer Shah, Krithika Suresh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell CarcinomaTrisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
Head & Neck|March 18, 2023
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancerJoshua D Smith, Megan L Ludwig, Apurva D Bhangale, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancerJoshua A Bauer, Bhavna Kumar, Kitrina G Cordell, et al.
Pageof 101